Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | DGKA | P23743 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 7/20 | 0.33 |
| ▸ | BCL9 | O00512 | 1/20 | 0.33 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.32 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20569206 | 0.90 | ADRA2A (0.34) | TSHRCYP1A2MAPTCYP4F2CYP4A11 | |
| SCHEMBL25814226 | 0.85 | ALDH1A1 (0.36) | ALDH1A1TSHRCYP1A2MGAMGAA | |
| SCHEMBL26309959 | 0.84 | CYP1A2 (0.40) | TSHRCYP1A2 | |
| SCHEMBL20569208 | 0.84 | CYP2C19 (0.37) | ALDH1A1TSHR | |
| SCHEMBL22184135 | 0.81 | CYP1A2 (0.31) | CYP1A2 | |
| SCHEMBL22184148 | 0.79 | TSHR (0.32) | TSHR | |
| SCHEMBL22184147 | 0.77 | — | — | |
| SCHEMBL26293409 | 0.76 | TSHR (0.33) | TSHR | |
| SCHEMBL22184150 | 0.75 | MGAM (0.33) | MGAMGAASIMGAM2 | |
| SCHEMBL22184086 | 0.74 | PSMB8 (0.31) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3630732-B1 | METHOD AND MOLECULES | MEDIMMUNE LLC (US) | 2023-07-12 | — | — | EP | disclosed |